These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21325058)
21. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene. Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835 [TBL] [Abstract][Full Text] [Related]
22. A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity. Schweizer RA; Atanasov AG; Frey BM; Odermatt A Mol Cell Endocrinol; 2003 Dec; 212(1-2):41-9. PubMed ID: 14654249 [TBL] [Abstract][Full Text] [Related]
23. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. San Millán JL; Botella-Carretero JI; Alvarez-Blasco F; Luque-Ramírez M; Sancho J; Moghetti P; Escobar-Morreale HF J Clin Endocrinol Metab; 2005 Jul; 90(7):4157-62. PubMed ID: 15827106 [TBL] [Abstract][Full Text] [Related]
25. 11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation. Verma M; Kipari TMJ; Zhang Z; Man TY; Forster T; Homer NZM; Seckl JR; Holmes MC; Chapman KE Brain Behav Immun; 2018 Mar; 69():223-234. PubMed ID: 29162555 [TBL] [Abstract][Full Text] [Related]
26. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons. Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016 [TBL] [Abstract][Full Text] [Related]
27. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism. Sigurjonsdottir HA; Andrew R; Stimson RH; Johannsson G; Walker BR Eur J Endocrinol; 2009 Sep; 161(3):375-80. PubMed ID: 19549748 [TBL] [Abstract][Full Text] [Related]
28. Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1. Odermatt A; Atanasov AG; Balazs Z; Schweizer RA; Nashev LG; Schuster D; Langer T Mol Cell Endocrinol; 2006 Mar; 248(1-2):15-23. PubMed ID: 16412558 [TBL] [Abstract][Full Text] [Related]
29. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316 [TBL] [Abstract][Full Text] [Related]
30. Involvement of GR and p300 in the induction of H6PD by cortisol in human amnion fibroblasts. Wang W; Guo C; Li W; Li J; Wang W; Myatt L; Sun K Endocrinology; 2012 Dec; 153(12):5993-6002. PubMed ID: 23125313 [TBL] [Abstract][Full Text] [Related]
31. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease. Hussey M; Holleran G; Smith S; Sherlock M; McNamara D Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959 [TBL] [Abstract][Full Text] [Related]
32. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients. Muñoz R; Carvajal C; Escalona A; Boza C; Pérez G; Ibáñez L; Fardella C Obes Surg; 2009 Jun; 19(6):764-70. PubMed ID: 18592327 [TBL] [Abstract][Full Text] [Related]
33. Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample. White PC J Clin Endocrinol Metab; 2005 Oct; 90(10):5880-3. PubMed ID: 16091483 [TBL] [Abstract][Full Text] [Related]
34. The rise in expression and activity of 11β-HSD1 in human mesenchymal progenitor cells induces adipogenesis through increased local cortisol synthesis. Blaschke M; Koepp R; Streit F; Beismann J; Manthey G; Seitz MT; Kragl A; Siggelkow H J Steroid Biochem Mol Biol; 2021 Jun; 210():105850. PubMed ID: 33639236 [TBL] [Abstract][Full Text] [Related]
36. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516 [TBL] [Abstract][Full Text] [Related]
37. Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes. Zhang J; Osslund TD; Plant MH; Clogston CL; Nybo RE; Xiong F; Delaney JM; Jordan SR Biochemistry; 2005 May; 44(18):6948-57. PubMed ID: 15865440 [TBL] [Abstract][Full Text] [Related]
38. 11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes. Itoi S; Terao M; Murota H; Katayama I Biochem Biophys Res Commun; 2013 Oct; 440(2):265-70. PubMed ID: 24055708 [TBL] [Abstract][Full Text] [Related]
39. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase. Tomlinson JW; Stewart PM Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811 [TBL] [Abstract][Full Text] [Related]